Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Gastrointestinal Oncology
|
July 11, 2026
Efficacy and safety of modified FLOT chemotherapy in gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study
Cody Eslinger, Oudai Sahwan, Fares Jamal, et al.
JCO Precision Oncology
|
March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma
Fares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Cancer Chemotherapy and Pharmacology
|
February 26, 2021
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
Wen Wee Ma, Mojun Zhu, Elaine T Lam, et al.
JCO Precision Oncology
|
November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic
Oudai Sahwan, Fares Jamal, Rish Pai, et al.
Advanced Biology
|
March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint Inhibitors
Mojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2022
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Mojun Zhu, Chunhua Chen, Nathan R Foster, et al.
JCI Insight
|
October 18, 2022
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
Tara L Hogenson, Hao Xie, William J Phillips, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Gastrointestinal Oncology
|
July 11, 2026
Efficacy and safety of modified FLOT chemotherapy in gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study
Cody Eslinger, Oudai Sahwan, Fares Jamal, et al.
JCO Precision Oncology
|
March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma
Fares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Cancer Chemotherapy and Pharmacology
|
February 26, 2021
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
Wen Wee Ma, Mojun Zhu, Elaine T Lam, et al.
JCO Precision Oncology
|
November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic
Oudai Sahwan, Fares Jamal, Rish Pai, et al.
Advanced Biology
|
March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint Inhibitors
Mojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2022
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Mojun Zhu, Chunhua Chen, Nathan R Foster, et al.
JCI Insight
|
October 18, 2022
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
Tara L Hogenson, Hao Xie, William J Phillips, et al.
Page
of 3